发明名称 Hepatitis c inhibitor peptides
摘要 Compound of formula (I) active against the Hepatitis C virus, wherein when Q is CH2, a is 0, b is 0 and B is an amide derivative; or when Q is N-Y wherein Y is H or C1-6 alkyl, then B is an acyl derivative; R6, when present, is C1-6 alkyl substituted with carboxyl; R5, when present, is C1-6 alkyl optionally substituted with carboxyl; when Q is either CH2 or N-Y, then Z is oxo or thioxo; R4 is C1-10alkyl, C3-7 cycloalkyl or C4-10 (alkylcycloalkyl); R3 is C1-10 alkyl optionally substituted with carboxyl, C3-7 cycloalkyl or C4-10 (alkylcycloalkyl); W is a proline derivative; R1' is hydrogen, and R1 is C1-6 alkyl optionnaly substituted with thiol; or R1 is C2-6 alkenyl; or R1' and R1 together form a 3- to 6-membered ring; and A is hydroxy or a pharmaceutically acceptable salt or ester thereof.
申请公布号 AU8795698(A) 申请公布日期 1999.03.01
申请号 AU19980087956 申请日期 1998.08.10
申请人 BOEHRINGER INGELHEIM (CANADA) LTD. 发明人 MONTSE LLINAS-BRUNET;MARC-ANDRE POUPART;JEAN RANCOURT;BRUNO SIMONEAU;YOULA TSANTRIZOS;DOMINIK WERNIC
分类号 A61K38/00;A61K38/21;A61P1/16;A61P31/12;C07K5/078;C07K5/083;C07K5/103;C07K5/107;C07K7/06;C07K7/08;C07K14/18 主分类号 A61K38/00
代理机构 代理人
主权项
地址